Concepedia

Ruud C. Wortel

RC

Statistics

Publications

14

Citations

1K

H-Index

14

Active since

2014

Affiliations

Erasmus MC Cancer Institute(Current)

The Netherlands Cancer Institute

University Medical Center Utrecht

Utrecht University

Erasmus University Rotterdam

Ruud C. Wortel is an author at Erasmus MC Cancer Institute specializing in medicine, treatment planning, and radiation oncology.

Publications per year

2014–2022

14

Publications

14

Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial

Luca Incrocci, Ruud C. Wortel, Wendimagegn Alemayehu et al. · The Lancet Oncology · 2016 · 478 citations

, , +14

Acute Toxicity After Image-Guided Intensity Modulated Radiation Therapy Compared to 3D Conformal Radiation Therapy in Prostate Cancer Patients

Ruud C. Wortel, Luca Incrocci, Floris J. Pos et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 122 citations

, , +16

Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts

Ruud C. Wortel, Luca Incrocci, Floris J. Pos et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 103 citations

, , +17

Dose–surface maps identifying local dose–effects for acute gastrointestinal toxicity after radiotherapy for prostate cancer

Ruud C. Wortel, Marnix G. Witte, Uulke A. van der Heide et al. · Radiotherapy and Oncology · 2015 · 60 citations

, , +17

Hyprofractionated Versus Conventionally Fractionated Radiation Therapy for Patients with Intermediate- or High-Risk, Localized, Prostate Cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial

Kim C. de Vries, Ruud C. Wortel, Esther Oomen‐de Hoop et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 58 citations

, , +17

1–5 of 14